Home>>Lipids>> Reactive O2/N2 Pathways>>ent-8-iso Prostaglandin F2α-d9

ent-8-iso Prostaglandin F2α-d9 (Synonyms: ent-8-epi PGF2αd9, ent-8-iso PGF2αd9, ent-15-F2t-Isoprostane-d9)

Catalog No.GC47292

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

ent-8-iso Prostaglandin F2α-d9 Chemical Structure

Cas No.: N/A

Size Price Stock Qty
10 μg
$221.00
In stock
25 μg
$524.00
In stock
50 μg
$996.00
In stock
100 μg
$1,767.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ent-8-iso-Prostaglandin F-d9 (ent-8-iso-PGF-d9) contains nine deuterium atoms at the 17, 17', 18, 18', 19, 19',20,20, and positions. It is intended for use as an internal standard for the quantification of ent-8-iso-PGF by GC- or LC-mass spectrometry. Isoprostanes are produced by the non-enzymatic, free-radical peroxidation of arachidonic acid. They have been used as biomarkers of oxidative stress, but they also have been found to have a potent biological activity. ent-8-iso Prostaglandin F (ent-8-iso PGF) is a potent vasoconstrictor of porcine retinal and brain microvessels with EC50 values of 31 and 54 nM, respectively.1

1.Hou, X., Robers, L.J., II, Gobeil, F., Jr., et al.Isomer-specific contractile effects of a series of synthetic F2-isoprostanes on retinal and cerebral microvasculatureFree Radical Biology & Medicine36(2)163-172(2004)

Reviews

Review for ent-8-iso Prostaglandin F2α-d9

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ent-8-iso Prostaglandin F2α-d9

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.